Skizofrénia: vizsgálatok itt: Puerto Rico
4 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Where
- San Juan
- Életkor
- 5 év to 17 év
- People
- 400 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT07424404 · EU 2025-524062-16-00 - 3. fázisTaking peopleA Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Where
- Bayamón, San Juan
- Életkor
- 55 év to 90 év
- People
- 406 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00 - 3. fázisTaking peopleNBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Where
- San Juan
- Életkor
- 18 év to 65 év
- People
- 600 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT07114874 · EU 2025-521216-19-00 - 3. fázisTaking peopleEfficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Where
- San Juan
- Életkor
- 18 év to 65 év
- People
- 560 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT07227818